Peter Howard Gann

College of Medicine, College of Medicine at Chicago - Clinical Science, Pathology

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

Peter Howard Gann

• Organizations
  College of Medicine
  
  College of Medicine at Chicago - Clinical Science
  
  Pathology
  
  College of Medicine
  
  College of Medicine at Chicago - Clinical Science
  
  Cancer Center
  
  Vice Chancellor for Research (OVCR)
  
  Research Resources Center
  
  Pharmacy
  
  Biopharmaceutical Sciences
  
  

H-Index:37

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Kirsten L. Greene; Peter C. Albertsen; Richard J. Babaian; H. Ballentine Carter; Peter H. Gann; Misop Han; Deborah Ann Kuban; A. Oliver Sartor; Janet L. Stanford; Anthony Zietman; et al.

  Prostate specific antigen best practice statement: 2009 update

  Journal of Urology. 2013;189(1 SUPPL):S2-S11.
  1

• 2.

  2013

  Boris Gershman; Irene M. Shui; Meir Stampfer; Elizabeth A. Platz; Peter H. Gann; Howard L. Sesso; Natalie DuPre; Edward Giovannucci; Lorelei A. Mucci

  Prediagnostic Circulating Sex Hormones Are Not Associated with Mortality for Men with Prostate Cancer

  European Urology. 2013.
  0

• 3.

  2013

  A. Jerome-Morais; S. Bera; W. Rachidi; P.H. Gann; A.M. Diamond

  The effects of selenium and the GPx-1 selenoprotein on the phosphorylation of H2AX

  Biochimica et Biophysica Acta - General Subjects. 2013;1830(6):3399-3406.
  0

• 4.

  2012

  Umaima Al-Alem; Peter H. Gann; Jeffrey Dahl; Richard B. Van Breemen; Vilas Mistry; Patricia M. W. Lam; Mark D. Evans; Linda Van Horn; Margaret E. Wright

  Associations between functional polymorphisms in antioxidant defense genes and urinary oxidative stress biomarkers in healthy, premenopausal women

  Genes and Nutrition. 2012;7(2):191-195.
  0

• 5.

  2012

  Margaret E. Wright; Phyllis Bowen; Jarmo Virtamo; Demetrius Albanes; Peter H. Gann

  Estimated phytanic acid intake and prostate cancer risk: A prospective cohort study

  International Journal of Cancer. 2012;131(6):1396-1406.
  2

• 6.

  2011

  Irene B. Helenowski; Edward F. Vonesh; Hakan Demirtas; Alfred W. Rademaker; Vijayalakshmi Ananthanarayanan; Peter H. Gann; Borko D. Jovanovic

  Defining reproducibility statistics as a function of the spatial covariance structures in biomarker studies

  International Journal of Biostatistics. 2011;7(1).
  0

• 7.

  2011

  Stacy Loeb; Edward F. Vonesh; E. Jeffrey Metter; H. Ballentine Carter; Peter H. Gann; William J. Catalona

  What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?

  Journal of Clinical Oncology. 2011;29(4):464-467.
  30

• 8.

  2011

  Emily N. Terry; Peter H. Gann; Robert Molokie; Michael Deininger; Alan M. Diamond

  Changes in the activity of the GPx-1 anti-oxidant selenoenzyme in mononuclear cells following imatinib treatment

  Leukemia Research. 2011;35(6):831-833.
  0

• 9.

  2011

  Viju Ananthanarayanan; Ryan J. Deaton; Anup Amatya; Virgilia MacIas; Ed Luther; Andre Kajdacsy-Balla; Peter H. Gann

  Subcellular localization of p27 and prostate cancer recurrence: Automated digital microscopy analysis of tissue microarrays

  Human Pathology. 2011;42(6):873-881.
  2

• 10.

  2011

  Stacy Loeb; Edward F. Vonesh; E. Jeffrey Metter; H. Ballentine Carter; Peter H. Gann; William J. Catalona

  Reply to P.F. Pinksy

  Journal of Clinical Oncology. 2011;29(24):3337.
  0

• 11.

  2010

  Peter H. Gann

  Prostate cancer: A closer look at the initial results from the REDUCE trial

  Nature Reviews Urology. 2010;7(10):535-537.
  2

• 12.

  2010

  Larisa Nonn; Avani Vaishnav; Lindsay Gallagher; Peter H. Gann

  mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: Valuable tool for risk assessment and prevention trials

  Experimental and Molecular Pathology. 2010;88(1):45-51.
  15

• 13.

  2010

  Szilard Asztalos; Peter H. Gann; Meghan K. Hayes; Larisa Nonn; Craig A. Beam; Yang Dai; Elizabeth L. Wiley; Debra A. Tonetti

  Gene expression patterns in the human breast after pregnancy

  Cancer Prevention Research. 2010;3(3):301-311.
  14

• 14.

  2010

  Peter H. Gann; Angela Fought; Ryan Deaton; William J. Catalona; Edward Vonesh

  Risk factors for prostate cancer detection after a negative biopsy: A novel multivariable longitudinal approach

  Journal of Clinical Oncology. 2010;28(10):1714-1720.
  17

• 15.

  2009

  Peter H. Gann

  Randomized trials of antioxidant supplementation for cancer prevention: First bias, now chance - Next, cause

  JAMA - Journal of the American Medical Association. 2009;301(1):102-103.
  26

• 16.

  2009

  Peter H. Gann

  Antioxidant supplementation and cancer prevention - Reply

  JAMA - Journal of the American Medical Association. 2009;301(18):1879.
  0

• 17.

  2009

  Larisa Nonn; Vijayalakshmi Ananthanarayanan; Peter H. Gann

  Evidence for field cancerization of the prostate

  Prostate. 2009;69(13):1470-1479.
  32

• 18.

  2009

  Kirsten L. Greene; Peter C. Albertsen; Richard J. Babaian; H. Ballentine Carter; Peter H. Gann; Misop Han; Deborah Ann Kuban; A. Oliver Sartor; Janet L. Stanford; Anthony Zietman; et al.

  Prostate Specific Antigen Best Practice Statement: 2009 Update

  Journal of Urology. 2009;182(5):2232-2241.
  130

• 19.

  2008

  Andrew W. Roddam; Naomi E. Allen; Paul Appleby; Timothy J. Key; Luigi Ferrucci; H. Ballentine Carter; E. Jeffrey Metter; Chu Chen; Noel S. Weiss; Annette Fitzpatrick; et al.

  Insulin-like growth factors, their binding proteins, and prostate cancer risk: Analysis of individual patient data from 12 prospective studies

  Annals of Internal Medicine. 2008;149(7):461-471.
  109

• 20.

  2007

  S.M. Gapstur; P. Kopp; P.H. Gann; B.C.-H. Chiu; L.A. Colangelo; K. Liu

  Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: The CARDIA Male Hormone Study

  International Journal of Obesity. 2007;31(4):685-691.
  15

• 21.

  2007

  Margaret E. Wright; Peter H. Gann

  Does active treatment improve survival in elderly men with localized prostate cancer? Commentary

  Nature Clinical Practice Urology. 2007;4(8):420-421.
  0

• 22.

  2007

  Ruth C. Travis; Timothy J. Key; Naomi E. Allen; Paul N. Appleby; Andrew W. Roddam; Sabina Rinaldi; Lars Egevad; Peter H. Gann; Sabine Rohrmann; et al.

  Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition

  International Journal of Cancer. 2007;121(6):1331-1338.
  42

• 23.

  2007

  Yael C. Cohen; Kenneth S. Liu; Norman L. Heyden; Alexandra D. Carides; Keaven M. Anderson; Anastasia G. Daifotis; Peter H. Gann

  Detection bias due to the effect of finasteride on prostate volume: A modeling approach for analysis of the prostate cancer prevention trial

  Journal of the National Cancer Institute. 2007;99(18):1366-1374.
  63

• 24.

  2007

  Maarten C. Bosland; Peter H. Gann

  Soy isoflavone consumption is not associated with increased risk of advanced prostate cancer [1]

  Cancer Epidemiology Biomarkers and Prevention. 2007;16(10):2169.
  2

• 25.

  2007

  Janet Van Adelsberg; Peter Gann; Amy T. Ko; Jan-Erik Damber; Christopher Logothetis; Michael Marberger; Bernd J. Schmitz-Drager; Andrea Tubaro; Celia J. Harms; Claus Roehrborn

  The VIOXX in prostate cancer prevention study: Cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups

  Current Medical Research and Opinion. 2007;23(9):2063-2070.
  11

• 26.

  2007

  Young L. Kim; David R. Jacobs Jr.; Myron D. Gross; Raymond C. Bergan; Peter H. Gann; Kiang Liu; Susan M. Gapstur

  Associations of serum carotenoid levels with serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in black men and white men

  Cancer Epidemiology Biomarkers and Prevention. 2007;16(12):2781-2783.
  1

• 27.

  2006

  Peter H. Gann; Angela S. Geiger; Irene B. Helenowski; Edward F. Vonesh; Robert T. Chatterton

  Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: Relationship to steroid precursors and response proteins

  Cancer Epidemiology Biomarkers and Prevention. 2006;15(1):39-44.
  12

• 28.

  2006

  Lawrence H. Kushi; Tim Byers; Colleen Doyle; Elisa V. Bandera; Marji McCullough; Ted Gansler; Kimberly S. Andrews; Michael J. Thun; Barbara Ainsworth; Rachel Ballard-Barbash; et al.

  American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity

  Ca-A Cancer Journal for Clinicians. 2006;56(5):254-281.
  261

• 29.

  2006

  Vijayalakshmi Ananthanarayanan; Ryan J. Deaton; Ximing J. Yang; Michael R. Pins; Peter H. Gann

  Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer

  BMC Cancer. 2006;6.
  28

• 30.

  2005

  V. Ananthanarayanan; M.R. Pins; R.E. Meyer; P.H. Gann

  Immunohistochemical assays in prostatic biopsies processed in Bouin's fixative

  Journal of Clinical Pathology. 2005;58(3):322-324.
  15

• 31.

  2005

  Robert T. Chatterton Jr.; Angela S. Geiger; Esnar T. Mateo; Irene B. Helenowski; Peter H. Gann

  Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: Effect of oral contraceptives and hormone replacement

  Journal of Clinical Endocrinology and Metabolism. 2005;90(3):1686-1691.
  20

• 32.

  2005

  Peter H. Gann; Misop Han

  The natural history of clinically localized prostate cancer

  Journal of the American Medical Association. 2005;293(17):2149-2151.
  3

• 33.

  2005

  Vijayalakshmi Ananthanarayanan; Ryan J. Deaton; Ximing J. Yang; Michael R. Pins; Peter H. Gann

  Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): Association with diagnosis of prostate cancer

  Prostate. 2005;63(4):341-346.
  30

• 34.

  2005

  Kevin T. McVary; Alfred Rademaker; Granville L. Lloyd; Peter Gann

  Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia

  Journal of Urology. 2005;174(4 I):1327-1333.
  107

• 35.

  2005

  Peter H. Gann; Ralph Kazer; Robert Chatterton; Susan Gapstur; Kim Thedford; Irene Helenowski; Sue Giovanazzi; Linda Van Horn

  Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: Effects on circulating IGF-I and its binding proteins in premenopausal women

  International Journal of Cancer. 2005;116(2):297-303.
  20

• 36.

  2005

  Peter H. Gann

  Intermediate biomarkers of lycopene/tomato effects in high-risk prostatic tissue

  Journal of Nutrition. 2005;135(8):2065S-2067S.
  2

• 37.

  2005

  Laura A. Colangelo; Brian C.-H. Chiu; Kiang Liu; Peter A. Kopp; Peter H. Gann; Susan M. Gapstur

  IGF-1, IGFBP-3, and nutritional factors in young black and white men: The CARDIA Male Hormone Study

  Nutrition and Cancer. 2005;53(1):57-64.
  7

• 38.

  2005

  June M. Chan; Peter H. Gann; Edward L. Giovannucci

  Role of diet in prostate cancer development and progression

  Journal of Clinical Oncology. 2005;23(32):8152-8160.
  170

• 39.

  2004

  Laura A. Colangelo; Susan M. Gapstur; Peter H. Gann; Alan R. Dyer

  Cigarette Smoking and Colorectal Carcinoma Mortality in a Cohort with Long-Term Follow-Up

  Cancer. 2004;100(2):288-293.
  37

• 40.

  2004

  Misop Han; Peter H. Gann; William J. Catalona

  Prostate-specific antigen and screening for prostate cancer

  Medical Clinics of North America. 2004;88(2):245-265.
  20

• 41.

  2004

  Robert T. Chatterton Jr.; Angela S. Geiger; Seema A. Khan; Irene B. Helenowski; Borko D. Jovanovic; Peter H. Gann

  Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women

  Cancer Epidemiology Biomarkers and Prevention. 2004;13(6):928-935.
  30

• 42.

  2004

  Rathi Ramakrishnan; Peter H. Gann; Elizabeth L. Wiley; Kamal K. Khurana; Seema A. Khan

  Normal breast lobular architecture in breast biopsy samples from breast cancer cases and benign disease controls

  Breast Cancer Research and Treatment. 2004;86(3):259-268.
  2

• 43.

  2004

  Ruth Etzioni; Seth Falcon; Peter H. Gann; Charles L. Kooperberg; David F. Penson; Meir J. Stampfer

  Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: Do combination tests improve detection?

  Cancer Epidemiology Biomarkers and Prevention. 2004;13(10):1640-1645.
  21

• 44.

  2004

  Timothy J. Key; Naomi Allen; Paul Appleby; Kim Overvad; Anne Tjønneland; Anthony Miller; Heiner Boeing; Dimitrios Karalis; Theodora Psaltopoulou; Franco Berrino; et al.

  Fruits and vegetables and prostate cancer: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  International Journal of Cancer. 2004;109(1):119-124.
  60

• 45.

  2004

  Susan M. Gapstur; Peter Kopp; Brian C-H. Chiu; Peter H. Gann; Laura A. Colangelo; Kiang Liu

  Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: The CARDIA male hormone study

  Cancer Epidemiology Biomarkers and Prevention. 2004;13(12):2208-2216.
  25

• 46.

  2003

  Ruth Etzioni; Charles Kooperberg; Margaret Pepe; Robert Smith; Peter H Gann

  Combining biomarkers to detect disease with application to prostate cancer.

  Biostatistics (Oxford, England). 2003;4(4):523-538.
  37

• 47.

  2003

  Peter H. Gann

  Informed consent for prostate-specific antigen testing

  Urology. 2003;61(1):5-6.
  4

• 48.

  2003

  Peter H. Gann; Monica Morrow

  Combined Hormone Therapy and Breast Cancer: A Single-Edged Sword

  Journal of the American Medical Association. 2003;289(24):3304-3306.
  5

• 49.

  2003

  Robert T. Chatterton Jr.; Angela S. Geiger; Peter H. Gann; Seema A. Khan

  Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue

  Journal of Steroid Biochemistry and Molecular Biology. 2003;86(2):159-166.
  21

• 50.

  2003

  Peter H. Gann; Robert T. Chatterton; Susan M. Gapstur; Kiang Liu; Daniel Garside; Sue Giovanazzi; Kim Thedford; Linda Van Horn

  The Effects of a Low-Fat/High-Fiber Diet on Sex Hormone Levels and Menstrual Cycling in Premenopausal Women: A 12-Month Randomized Trial (the Diet and Hormone Study)

  Cancer. 2003;98(9):1870-1879.
  28

• 51.

  2003

  Peter H. Gann; Frederick Khachik

  Tomatoes or lycopene versus prostate cancer: Is evolution anti-reductionist?

  Journal of the National Cancer Institute. 2003;95(21):1563-1565.
  27

• 52.

  2002

  Peter H. Gann; Jing Ma; William J. Catalona; Meir J. Stampfer

  Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: A prospective evaluation

  Journal of Urology. 2002;167(6):2427-2434.
  39

• 53.

  2002

  Laura A. Colangelo; Susan M. Gapstur; Peter H. Gann; Alan R. Dyer; Kiang Liu

  Colorectal cancer mortality and factors related to the insulin resistance syndrome

  Cancer Epidemiology Biomarkers and Prevention. 2002;11(4):385-391.
  134

• 54.

  2002

  Susan M. Gapstur; Peter H. Gann; Peter Kopp; Laura Colangelo; Christopher Longcope; Kiang Liu

  Serum androgen concentrations in young men: A longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study

  Cancer Epidemiology Biomarkers and Prevention. 2002;11(10 I):1041-1047.
  121

• 55.

  2002

  Ruth Etzioni; David F. Penson; Julie M. Legler; Dante Di Tommaso; Rob Boer; Peter H. Gann; Eric J. Feuer

  Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends

  Journal of the National Cancer Institute. 2002;94(13):981-990.
  454

• 56.

  2002

  June M. Chan; Meir J. Stampfer; Jing Ma; Peter Gann; J. Michael Gaziano; Michael Pollak; Edward Giovannucci

  Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer

  Journal of the National Cancer Institute. 2002;94(14):1099-1106.
  291

• 57.

  2002

  P.H. Gann

  Androgenic hormones and prostate cancer risk: status and prospects.

  IARC scientific publications. 2002;156:283-288.
  1

• 58.

  2001

  Peter H. Gann; Robert T. Chatterton; Chung Lee

  Peptide growth factors as biomarkers of prostate cancer risk

  Epidemiologic Reviews. 2001;23(1):67-71.
  3

• 59.

  2001

  June M. Chan; Meir J. Stampfer; Jing Ma; Peter H. Gann; J. Michael Gaziano; Edward L. Giovannucci

  Dairy products, calcium, and prostate cancer risk in the physicians' health study

  American Journal of Clinical Nutrition. 2001;74(4):549-554.
  123

• 60.

  2001

  S.M. Gapstur; P.H. Gann; L.A. Colangelo; R. Barron-Simpson; P. Kopp; A. Dyer; K. Liu

  Postload plasma glucose concentration and 27-year prostate cancer mortality (United States)

  Cancer Causes and Control. 2001;12(8):763-772.
  24

• 61.

  2001

  P.H. Gann; S. Giovanazzi; L. Van Horn; A. Branning; Jr. Chatterton R.T.

  Saliva as a medium for investigating intra- and interindividual differences in sex hormone levels in premenopausal women

  Cancer Epidemiology Biomarkers and Prevention. 2001;10(1):59-64.
  29

• 62.

  2001

  S.M. Gapstur; P. Gann

  Is pancreatic cancer a preventable disease?

  Journal of the American Medical Association. 2001;286(8):967-968.
  7

• 63.

  2000

  Susan M. Gapstur; Peter H. Gann; William Lowe; Kiang Liu; Laura Colangelo; Alan Dyer

  Abnormal glucose metabolism and pancreatic cancer mortality

  Journal of the American Medical Association. 2000;283(19):2552-2558.
  202

• 64.

  2000

  P. Kulkarni; A.B. Lowenfels; S.M. Gapstur; K. Liu; P.H. Gann; A. Dyer

  Relationship between glucose metabolism and pancreatic cancer [1] (multiple letters)

  Journal of the American Medical Association. 2000;284(12):1512-1513.
  2

• 65.

  1999

  P.T. Ellison; S.F. Lipson; R.T. Chatterton; Y.-C. Lu; G.R. Bentley; P.H. Gann; K.R. Hodges

  Salivary estradiol - A viable alternative? [4] (multiple letters)

  Fertility and Sterility. 1999;72(5):951-952.
  11

• 66.

  1999

  Peter H. Gann; Karin G. Klein; Robert T. Chatterton; Allison E. Ellman; John T. Grayhack; Robert B. Nadler; Chung Lee

  Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates

  Prostate. 1999;40(4):248-255.
  23

• 67.

  1999

  Andreas Stang; Robert J. Glynn; Peter H. Gann; James O. Taylor; Charles H. Hennekens

  Cancer occurrence in the elderly: Agreement between three major data sources

  Annals of Epidemiology. 1999;9(1):60-67.
  9

• 68.

  1999

  Yu-Cai Lu; Gillian R. Bentley; Peter H. Gann; Kelly R. Hodges; Robert T. Chatterton

  Salivary estradiol and progesterone levels in conception and nonconception cycles in women: Evaluation of a new assay for salivary estradiol

  Fertility and Sterility. 1999;71(5):863-868.
  61

• 69.

  1999

  Edward Giovannucci; Meir J. Stampfer; Andrew Chan; Krishna Krithivas; Peter H. Gann; Charles H. Hennekens; Philip W. Kantoff

  CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians

  Prostate. 1999;39(2):130-134.
  48

• 70.

  1999

  Peter H. Gann; Jing Ma; Edward Giovannucci; Walter Willett; Frank M. Sacks; Charles H. Hennekens; Meir J. Stampfer

  Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis

  Cancer Research. 1999;59(6):1225-1230.
  398

• 71.

  1999

  Peter H. Gann; Susan A. Colilla; Susan M. Gapstur; David J. Winchester; David P. Winchester

  Factors associated with axillary lymph node metastasis from breast carcinoma. Descriptive and predictive analyses

  Cancer. 1999;86(8):1511-1519.
  56

• 72.

  1998

  Jing Ma; Meir J. Stampfer; Peter H. Gann; Heather L. Hough; Edward Giovannucci; Karl T. Kelsey; Charles H. Hennekens; David J. Hunter

  Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians

  Cancer Epidemiology Biomarkers and Prevention. 1998;7(5):385-390.
  132

• 73.

  1998

  Peter H. Gann

  Diet and prostate cancer risk: The embarrassment of riches

  Cancer Causes and Control. 1998;9(6):541-543.
  2

• 74.

  1998

  June M. Chan; Meir J. Stampfer; Edward Giovannucci; Peter H. Gann; Jing Ma; Peter Wilkinson; Charles H. Hennekens; Michael Pollak

  Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study

  Science. 1998;279(5350):563-566.
  1400

• 75.

  1997

  Peter H. Gann; Robert Chatterton; Kirsten Vogelsong; John T. Grayhack; Chung Lee

  Epidermal growth factor-related peptides in human prostatic fluid: Sources of variability in assay results

  Prostate. 1997;32(4):234-240.
  9

• 76.

  1997

  Peter Gann; Robert Chatterton; Kirsten Vogelsong; Joséc Dupuis; Allison Ellman

  Mitogenic growth factors in breast fluid obtained from healthy women: Evaluation of biological and extraneous sources of variability

  Cancer Epidemiology Biomarkers and Prevention. 1997;6(6):421-428.
  27

• 77.

  1997

  P.H. Gann

  Interpreting recent trends in prostate cancer incidence and mortality.

  Epidemiology (Cambridge, Mass.). 1997;8(2):117-120.
  43

• 78.

  1996

  Peter H. Gann; Charles H. Hennekens; Jing Ma; Christopher Longcope; Meir J. Stampfer

  Prospective study of sex hormone levels and risk of prostate cancer

  Journal of the National Cancer Institute. 1996;88(16):1118-1126.
  467

• 79.

  1996

  S.M. Gapstur; J. Dupuis; P. Gann; S. Collila; D.P. Winchester

  Hormone receptor status of breast tumors in black, hispanic, and non- Hispanic white women: An analysis of 13,239 cases

  Cancer. 1996;77(8):1465-1471.
  77

• 80.

  1996

  P.H. Gann

  Prostate-specific antigen screening for prostate cancer: Issues involving test validity

  Endocrine-Related Cancer. 1996;3(3):179-189.
  1

• 81.

  1995

  P.H. Gann; C.H. Hennekens; M.J. Stampfer

  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

  Journal of the American Medical Association. 1995;273(4):289-294.
  492

• 82.

  1995

  P.H. Gann; C.H. Hennekens; C. Longcope; W. Verhoek-Oftedahl; F. Grodstein; M.J. Stampfer

  A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

  Prostate. 1995;26(1):40-49.
  105

• 83.

  1995

  P.H. Gann; M.L. Daviglus; A.R. Dyer; J. Stamler

  Heart rate and prostate cancer mortality: Results of a prospective analysis

  Cancer Epidemiology Biomarkers and Prevention. 1995;4(6):611-616.
  36

• 84.

  1995

  D.J. Brunswick; K.G. Marshall; J. Meyerhoff; E.H. Livingston; J.C. Peirce; P.H. Gann; C.H. Hennekens; M.J. Stampfer

  The utility of prostate-specific antigen for detecting prostate cancer [1]

  Journal of the American Medical Association. 1995;274(8):607-609.
  3

• 85.

  1994

  Peter H. Gann; Charles H. Hennekens; Frank M. Sacks; Francine Grodstein; Edward L. Giovannucci; Meir J. Stampfer

  Prospective study of plasma fatty acids and risk of prostate cancer

  Journal of the National Cancer Institute. 1994;86(4):281-286.
  231

• 86.

  1994

  H. Gronberg; L. Damber; J.-E. Damber; P.C. Walsh; P.H. Gann

  Studies of genetic factors in prostate cancer in a twin population

  Journal of Urology. 1994;152(5 I):1484-1489.
  93

• 87.

  1994

  Peter H. Gann; Franklin A. Neva; Albert A. Gam

  A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis

  Journal of Infectious Diseases. 1994;169(5):1076-1079.
  118

• 88.

  1994

  P.H. Gann; C.H. Hennekens; F.M. Sacks

  Erratum: Prospective study of plasma fatty acids and risk of prostate cancer (Journal of the National Cancer Institute (1994) 86 (281-286))

  Journal of the National Cancer Institute. 1994;86(9):728.
  0

• 89.

  1994

  J.M. Wiecha; P. Gann

  Does maternal prenatal care use predict infant immunization delay?

  Family Medicine. 1994;26(3):172-178.
  18

• 90.

  1993

  S.K. Melville; R. Luckmann; J. Coghlin; P. Gann

  Office systems for promoting screening mammography: A survey of primary care practices

  Journal of Family Practice. 1993;37(6):569-574.
  13

• 91.

  1993

  P.H. Gann; J.E. Manson; R.J. Glynn; J.E. Buring; C.H. Hennekens

  Low-dose aspirin and incidence of colorectal tumors in a randomized trial

  Journal of the National Cancer Institute. 1993;85(15):1220-1224.
  255

• 92.

  1993

  P. Gann; S.K. Melville; R. Luckmann

  Characteristics of primary care office systems as predictors of mammography utilization

  Annals of Internal Medicine. 1993;118(11):893-898.
  28

• 93.

  1993

  M.J. Reasor; S.K. Hammond; J. Coghlin; P.H. Gann; P.L. Skipper; S.R. Tannenbaum

  Re: Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers

  Journal of the National Cancer Institute. 1993;85(20):1693-1696.
  2

• 94.

  1993

  S.K. Hammond; J. Coghlin; P.H. Gann; M. Paul; K. Taghizadeh; P.L. Skipper; S.R. Tannenbaum

  Relationship between environmental tobacco smoke exposure and carcinogen- hemoglobin adduct levels in nonsmokers

  Journal of the National Cancer Institute. 1993;85(6):474-478.
  70

• 95.

  1993

  J.M. Wiecha; P. Gann

  Provider confidence in breast examination.

  The Family practice research journal. 1993;13(1):37-41.
  12

• 96.

  1993

  S. Katharine Hammond; Jacalyn Coghlin; Peter H. Gann; Paul L. Skipper; Steven R. Tannenbaum

  Response

  Journal of the National Cancer Institute. 1993;85(20):1694-1696.
  0

• 97.

  1991

  L.S. Caplan; P.H. Gann

  Screening mammography (Reply I)

  Journal of the American Medical Association. 1991;265(1):27.
  0

• 98.

  1991

  P.H. Gann; S. Anderson; M.B. Regan

  Shifts in medical student beliefs about AIDS after a comprehensive training experience

  American Journal of Preventive Medicine. 1991;7(3):172-177.
  11

• 99.

  1991

  Jacalyn Coghlin; Peter H. Gann; S. Katharine Hammond; Paul L. Skipper; Koli Taghizadeh; Maureen Paul; Steven R. Tannenbaum

  4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero

  Journal of the National Cancer Institute. 1991;83(4):274-280.
  42

• 100.

  1990

  P.H. Gann

  Truth or consequences: When the study reintroduces the disease agent

  Epidemiology. 1990;1(3):192-194.
  5

• 101.

  1990

  Billy W. Day; Paul L. Skipper; John S. Wishnok; Jacalyn Coghlin; S. Katherine Hammond; Peter Gann; Steven R. Tannenbaum

  Identification of an in vivo chrysene diol epoxide adduct in human hemoglobin

  Chemical Research in Toxicology. 1990;3(4):340-343.
  8

• 102.

  1990

  S.M. Brooks; D.B. Baker; P.H. Gann; A.M. Jarabek; V. Hertzberg; J. Gallagher; R.E. Biagini; I.L. Bernstein

  Cold air challenge and platinum skin reactivity in platinum refinery workers. Bronchial reactivity precedes skin prick response

  Chest. 1990;97(6):1401-1407.
  23

• 103.

  1990

  P.H. Gann; J.E. Herrmann; L. Candib; R.W. Hudson

  Accuracy of Chlamydia trachomatis antigen detection methods in a low-prevalence population in a primary care setting

  Journal of Clinical Microbiology. 1990;28(7):1580-1585.
  6

• 104.

  1990

  D.B. Baker; P.H. Gann; S.M. Brooks; J. Gallagher; I.L. Bernstein

  Cross-sectional study of platinum salts sensitization among precious metals refinery workers

  American Journal of Industrial Medicine. 1990;18(6):653-664.
  53

• 105.

  1989

  J. Coghlin; S.K. Hammond; P.H. Gann

  Development of epidemiologic tools for measuring environmental tobacco smoke exposure

  American Journal of Epidemiology. 1989;130(4):696-704.
  62

• 106.

  1989

  P. Gann; L. Nghiem; S. Warner

  Pregnancy characteristics and outcomes of Cambodian refugees

  American Journal of Public Health. 1989;79(9):1251-1257.
  7

• 107.

  1985

  Raymond E. Biagini; I.Leonard Bernstein; Joan S. Gallagher; William J. Moorman; Stuart Brooks; Peter H. Gann

  The diversity of reaginic immune responses to platinum and palladium metallic salts

  The Journal of Allergy and Clinical Immunology. 1985;76(6):794-802.
  42

• 108.

  1982

  P. Gann; K.D. Rosenman

  Conclusions questioned in brain tumor excess study

  Journal of Occupational Medicine. 1982;24(6):428-429+432.
  0

• 109.

  1982

  J.S. Gallagher; D. Baker; P.H. Gann

  A cross sectional investigation of workers exposed to platinum salts

  Journal of Allergy and Clinical Immunology. 1982;69(1 II):165.
  0

• 110.

  1982

  P. Gann; J. Roseman

  Hazards of metal processing.

  Journal of the American Medical Association. 1982;248(13):1580.
  1

• 111.

  1980

  A.K. Bahn; J.L. Mills; P.J. Snyder; P.H. Gann; L. Houten; O. Bialik; L. Hollmann; R.D. Utiger

  Hypothyroidism in workers exposed to polybrominated biphenyls

  New England Journal of Medicine. 1980;302(1):31-33.
  40

• 112.

  1979

  S.W. Rosen; P. Gann; A.D. Rogol

  Congenital anosmia: Detection thresholds for seven odorant classes in hypogonadal and eugonadal patients

  Annals of Otology, Rhinology and Laryngology. 1979;88(2 I):288-292.
  18